Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: A prospective observational study

Critical Care

Volumn 16, Issue 4, 2012, Pages

  Haupt, Thomas H ^a   Petersen, Janne ^a   Ellekilde, Gertrude ^a   Klausen, Henrik H ^a   Thorball, Christian W ^a   Eugen Olsen, Jesper ^a   Andersen, Ove ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; BIOLOGICAL MARKER;

ADULT; AGED; ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX SCORE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; DISEASE SEVERITY; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; ICD-10; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REGISTER; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVOR; ACUTE DISEASE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; HOSPITAL MORTALITY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ACUTE DISEASE; AGED; BIOMARKERS; COMORBIDITY; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; PATIENT READMISSION; PROSPECTIVE STUDIES; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; REGISTRIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84864942108     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11434     Document Type: Article

References (20)

1. Montuori N, Ragno P. Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR. Front Biosci 2009, 14:2494-2503.
2. Blasi F, Sidenius N. The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett 2010, 584:1923-1930. 10.1016/j.febslet.2009.12.039, 20036661.
3. Eugen-Olsen J, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P, Gomes VF, Lisse I. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. Int J Tuberc Lung Dis 2002, 6:686-692.
4. Sidenius N, Sier CF, Ullum H, Pedersen BK, Lepri AC, Blasi F, Eugen-Olsen J. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 2000, 96:4091-4095.
5. Wittenhagen P, Andersen JB, Hansen A, Lindholm L, Ronne F, Theil J, Tvede M, Eugen-Olsen J. Plasma soluble urokinase plasminogen activator receptor in children with urinary tract infection. Biomark Insights 2011, 6:79-82. 3169345, 21918598.
6. Koch A, Voigt S, Kruschinski C, Sanson E, Duckers H, Horn A, Yagmur E, Zimmermann H, Trautwein C, Tacke F. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011, 15:R63. 10.1186/cc10037, 3221996, 21324198.
7. Thuno M, Macho B, Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009, 27:157-172.
8. Huttunen R, Syrjanen J, Vuento R, Hurme M, Huhtala H, Laine J, Pessi T, Aittoniemi J. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med 2011, 270:32-40. 10.1111/j.1365-2796.2011.02363.x, 21332843.
9. Rabna P, Andersen A, Wejse C, Oliveira I, Gomes VF, Haaland MB, Aaby P, Eugen-Olsen J. High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test. Trop Med Int Health 2009, 14:986-994. 10.1111/j.1365-3156.2009.02328.x, 19725925.
10. Christensen S, Johansen MB, Christiansen CF, Jensen R, Lemeshow S. Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care. Clin Epidemiol 2011, 3:203-211. 3130905, 21750629.
11. Eugen-Olsen J. suPAR - a future risk marker in bacteremia. J Intern Med 2011, 270:29-31. 10.1111/j.1365-2796.2011.02372.x, 21366732.
12. Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, Petersen J, Pielak T, Møller LN, Jeppesen J, Lyngbaek S, Fenger M, Olsen MH, Hildebrandt PR, Borch-Johnsen K, Jørgensen T, Haugaard SB. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 2010, 268:296-308. 10.1111/j.1365-2796.2010.02252.x, 20561148.
13. Riisbro R, Christensen IJ, Hogdall C, Brunner N, Hogdall E. Soluble urokinase plasminogen activator receptor measurements: influence of sample handling. Int J Biol Markers 2001, 16:233-239.
14. Januel JM, Luthi JC, Quan H, Borst F, Taffe P, Ghali WA, Burnand B. Improved accuracy of co-morbidity coding over time after the introduction of ICD-10 administrative data. BMC Health Serv Res 2011, 11:194. 10.1186/1472-6963-11-194, 3170597, 21849089.
15. Ostrowski SR, Piironen T, Hoyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients. J Acquir Immune Defic Syndr 2005, 39:23-31. 10.1097/01.qai.0000157950.02076.a6, 15851910.
16. Pebys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003, 112:299.
17. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011, 17:952-960. 10.1038/nm.2411, 21804539.
18. Berres ML, Schlosser B, Berg T, Trautwein C, Wasmuth HE. Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection. J Clin Gastroenterol 2011, 46:334-338.
19. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Res Methodol 2011, 11:83.
20. Kofoed K, Eugen-Olsen J, Petersen J, Larsen K, Andersen O. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor. Eur J Microbiol Infect Dis 2008, 27:375-83.